Literature DB >> 23973269

The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument.

Tim A Kanters1, Ans T van der Ploeg, Werner B F Brouwer, Leona Hakkaart.   

Abstract

BACKGROUND: Patients with Pompe disease, a rare progressive neuromuscular disorder, receive a considerable amount of informal care. In this study, we examined the impact of providing informal care to patients with Pompe disease.
METHODS: Caregivers were administered various instruments, which measured the (impact of) informal care in the context of Pompe disease. Patients' quality of life and use of a wheelchair and respiratory support were used to investigate the impact of disease severity on the burden and well-being of caregivers.
RESULTS: Of all Dutch patients with Pompe disease, 88 indicated to receive informal care, of which 67 (76%; 67 caregivers) participated in this study. On average, caregivers provided 17.7 hours of informal care per week. Higher disease burden was associated with more hours of informal care. Caregivers experienced burden due to caregiving. Half of the informal caregivers reported mental health problems and problems with daily activities due to providing informal care. Physical health problems occurred in 40% of informal caregivers. Caregiver burden was higher for patients with a lower quality of life and for wheelchair dependent patients. Burden was not associated with respiratory support. Caregivers reported deriving personal fulfillment from caregiving and, on average, would become unhappier if someone else were to take over their care activities.
CONCLUSIONS: The provision of informal care causes burden to caregivers. However, caregivers also value caring for their loved ones themselves. The study may help physicians and policy makers to design measures to support informal caregivers.
© 2013.

Entities:  

Keywords:  Caregiver burden; CarerQol instrument; Informal care; Pompe disease

Mesh:

Year:  2013        PMID: 23973269     DOI: 10.1016/j.ymgme.2013.07.020

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  6 in total

1.  Health-Related Quality of Life and Perceived Burden of Informal Caregivers of Patients with Rare Diseases in Selected European Countries.

Authors:  Cristina Valcárcel-Nazco; Yolanda Ramallo-Fariña; Renata Linertová; Juan Manuel Ramos-Goñi; Lidia García-Pérez; Pedro Serrano-Aguilar
Journal:  Int J Environ Res Public Health       Date:  2022-07-05       Impact factor: 4.614

2.  Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs?

Authors:  R Rodriguez-Monguio; T Spargo; E Seoane-Vazquez
Journal:  Orphanet J Rare Dis       Date:  2017-01-05       Impact factor: 4.123

Review 3.  The humanistic burden of Pompe disease: are there still unmet needs? A systematic review.

Authors:  Benedikt Schoser; Deborah A Bilder; David Dimmock; Digant Gupta; Emma S James; Suyash Prasad
Journal:  BMC Neurol       Date:  2017-11-22       Impact factor: 2.474

4.  Quality of Life Among Informal Caregivers of Patients With Degenerative Cervical Myelopathy: Cross-Sectional Questionnaire Study.

Authors:  Oliver Daniel Mowforth; Benjamin Marshall Davies; Mark Reinhard Kotter
Journal:  Interact J Med Res       Date:  2019-11-07

Review 5.  A systematic review and integrative sequential explanatory narrative synthesis: The psychosocial impact of parenting a child with a lysosomal storage disorder.

Authors:  Sadie Hassall; Debbie Michelle Smith; Stewart Rust; Anja Wittkowski
Journal:  J Inherit Metab Dis       Date:  2022-02-24       Impact factor: 4.750

6.  The Role of Associations in Reducing the Emotional and Financial Impact on Parents Caring for Children with Duchenne Muscular Dystrophy: A Cross-Cultural Study.

Authors:  Alicia Aurora Rodríguez; Imanol Amayra; Juan Francisco López-Paz; Oscar Martínez; Maitane García; Mónika Salgueiro; Mohammad Al-Rashaida; Paula María Luna; Paula Pérez-Nuñez; Nicole Passi; Irune García; Javiera Ortega
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.